Dana Herndon
Overview
Explore the profile of Dana Herndon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
32
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crawford J, Herndon D, Gmitter K, Weiss J
Future Oncol
. 2024 Apr;
20(21):1515-1530.
PMID: 38587388
Side effects from chemotherapy-induced myelosuppression can negatively affect patients' quality of life (QoL). Neutropenia increases infection risk, and anemia frequently results in debilitating fatigue. Additionally, the bleeding risk associated with...
2.
Schrock A, Frampton G, Herndon D, Greenbowe J, Wang K, Lipson D, et al.
Clin Cancer Res
. 2016 Mar;
22(13):3281-5.
PMID: 26933124
Purpose: Reliable detection of drug-sensitive activating EGFR mutations is critical in the care of advanced non-small cell lung cancer (NSCLC), but such testing is commonly performed using a wide variety...
3.
Levy B, Chioda M, Herndon D, Longshore J, Mohamed M, Ou S, et al.
Oncologist
. 2015 Sep;
20(10):1175-81.
PMID: 26330460
The recent discovery of relevant biomarkers has reshaped our approach to therapy selection for patients with non-small cell lung cancer. The unprecedented outcomes demonstrated with tyrosine kinase inhibitors in molecularly...